- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04118595
Reducing the Transition From Acute to Chronic Musculoskeletal Pain Among Older Adults (BETTER)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be assigned to one of the three treatment arms using 1:1:1 randomization, stratified by access to a primary care provider, using randomly permuted blocks with random block sizes. (Primary care access will be determined using Source of Care questions from the Primary Care Assessment tool.) Randomization will be based on computer generated lists and allocated within subgroups based on access to a PCP using REDCap's integrated randomization module. One arm will receive the full intervention (educational video, telecare call, transmission of clinical information to the PCP), one will view the educational video only, and one will receive usual care. The investigators decided against a 2x2 factorial design, which would add a telecare only arm, because our team' s collective understanding is that a basic understanding of pain management (as provided by the educational video) is essential for effective shared decision-making (SDM) and often missing among older patients. Screening, consent, randomization, and assessments will be completed by the study coordinator.
Interventions
Educational Video: Development of the original video was funded by the John A. Hartford Foundation and used a systematic approach that included a review of literature and current pain management guidelines and input from emergency physicians, geriatricians, and experts in pharmacology, physical therapy, and risk communication. The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors. Each video section is followed by a multiple-choice question to promote interaction and reinforce learning. The actress for the 13-minute video is a 56-year-old mixed-race woman who presents herself as a healthcare provider. The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit. A link to the video is emailed or texted to the patient.
Telecare: Telecare will be provided via a protocol-guided phone call from a nurse care manager 48-72 hours after discharge. The call is designed to support patient decision-making regarding analgesics and behaviors following the content presented in the video. Before the call, the nurse will review the note from the index visit to obtain information about comorbidities, medications, allergies, and the patient's evaluation and treatment in the ED. Topics covered in the call will include discussion of pain management goals and priorities, current analgesic use, non-pharmacologic methods of pain management, warnings about potential side effects, and open-ended questions to address additional patient care needs. Conversations will be guided by an SDM framework in which the nurse elicits information from the patient, then discusses with the patient alternative strategies, and actively elicits feedback from the patient. Patients will be encouraged to follow-up with their PCP; uninsured patients will be referred to local free or low-cost medical clinics. The telecare call is designed to last 15 minutes and the nurse will be trained to complete the call in 15 minutes.
Correspondence with PCP: Following the telecare conversation, the nurse will enter a note in the Electronic Health Record (EHR) documenting the patient's current clinical status, information reviewed, and any recommendations or referrals made. The nurse will then share this note directly with the patient's PCP using a secure e-mail or an electronic message within the EHR if the PCP is a University of North Carolina (UNC)-affiliated provider. (If the PCP's email address is not available, the research staff will contact the PCP or their office by phone to obtain an email address or fax number.) This communication with also include: (1) The date, time, location and reason for the initial visit; (2) Results of diagnostics studies; (3) Discharge prescriptions/recommendations; (4) A summary of and link to the video, explaining the emphasis on patient knowledge and SDM; (5) summary of the telecare conversation; and (6) encouragement for follow-up. PCPs will be asked to confirm receipt of this message.
*Study outcome measures as described in this CT.gov report have been revised as of September 6, 2023 in order to reflect the final Master Protocol.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 50 years and older
- Present to UNC ED patient with primary complaint of acute musculoskeletal pain
- Average pain score >/= 4 on 0-10 scale
- Expected discharge from the ED
Exclusion Criteria:
- patient does not speak English
- primary pain located in the head, chest, or abdomen
- pain due to ischemia, infection, or some other cause not due to MSP (blood clot, kidney stone, etc.)
- primary pain due to self-injury
- patient is critically ill determined by an acuity score of 1 in the tracking board
- diagnosis of somatoform disorder, schizophrenia, dementia, or bipolar disorder
- patient is a prisoner or in police custody
- self-reported daily opioid use for more than 2 weeks
- resides in a nursing home or is homeless
- at-risk alcohol use
- speech, hearing, vision problems
- cognitively impaired (6-item Brief Screener)
- nonworking phone number (follow-up occurs via phone calls)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Full Intervention (Video + Telecare + PCP communication)
Patients in this arm will watch an interactive pain management video; receive a pain assessment phone call and be given medication and behavioral pain management strategy recommendations; and an index visit and telecare summary will be shared with patient's primary care provider.
|
Educational Video: Development of the original video was funded by the John A. Hartford Foundation and used a systematic approach that included a review of literature and current pain management guidelines and input from emergency physicians, geriatricians, and experts in pharmacology, physical therapy, and risk communication.
The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors.
Each video section is followed by a multiple-choice question to promote interaction and reinforce learning.
The actress for the 13-minute video is a 56-year-old mixed-race woman who presents herself as a healthcare provider.
The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit.
A link to the video is emailed or texted to the patient.
Telecare will be provided via a protocol-guided phone call from a nurse care manager 48-72 hours after discharge from the ED or orthopedic urgent care.
The call is designed to support patient decision-making regarding analgesics and behaviors following the content presented in the video.
Topics covered in the call will include discussion of goals and priorities the patient has for their pain management, current prescriptions and analgesic use (and adjustments if needed), non-pharmacologic methods of pain management, warnings about potential side effects, current healthcare utilization, and open-ended questions to address additional patient care needs.
Conversations will be guided by a shared decision making framework in which the nurse suggests pain management options, discusses their pros and cons, and actively elicits feedback from the patient.
The telecare call is designed to last 15 minutes.
Following the telecare conversation, a note will be sent directly to the patient's primary care provider using a secure email or an electronic message that includes: 1) The date, time, location and reason for the index visit; (2) Results of diagnostics studies; (3) Discharge prescriptions/ recommendations; (4) A summary of and link to the video, explaining the emphasis on patient knowledge and SDM; (5) A summary of the telecare conversation; and (6) Encouragement for follow-up.
PCPs will be asked to confirm receipt of this message.
|
Experimental: Video-only Intervention
Patients in this arm will watch an interactive pain management video.
|
Educational Video: Development of the original video was funded by the John A. Hartford Foundation and used a systematic approach that included a review of literature and current pain management guidelines and input from emergency physicians, geriatricians, and experts in pharmacology, physical therapy, and risk communication.
The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors.
Each video section is followed by a multiple-choice question to promote interaction and reinforce learning.
The actress for the 13-minute video is a 56-year-old mixed-race woman who presents herself as a healthcare provider.
The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit.
A link to the video is emailed or texted to the patient.
|
No Intervention: Usual Care
Patients will receive the typical care provided by medical personnel for their acute pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score
Time Frame: Month 1 (following ED or orthopedic urgent care visit) to Month 6
|
The Brief Pain Inventory-Short Form (BPI-SF) is an 11-item measure of pain severity and pain interference.
Patients will rate their pain severity and interference over the past week on a 0-10 numeric scale at 3 discrete time periods (1, 3, and 6 months).
End points for the severity items include 0 which equals "no pain" and 10 which equals "pain as bad as you can imagine."
End points for the interference items include 0 which equals "does not interfere" and 10 "completely interferes."
Higher scores reflect more pain severity and more pain interference.
A composite score will be calculated by averaging scores from both the pain severity and interference items (all 11-items).
Results from the 3 time periods will be analyzed longitudinally.
|
Month 1 (following ED or orthopedic urgent care visit) to Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score
Time Frame: Up to 6 months
|
The BPI-SF is an 11-item measure of pain severity and pain interference with severity entailing 4 of the questions.
Patient's will rate their pain severity over the past week on a 0-10 numeric rating scale, with a higher score reflecting more pain.
End points include 0 which equals "no pain" and 10 which equals "pain as bad as you can imagine."
Answers to each of the 4 questions will be reported as mean values for each time point (Month 1, 3, and 6).
|
Up to 6 months
|
Mean Pain Interference on the BPI-SF Score
Time Frame: Up to 6 months
|
The BPI-SF is an 11-item measure of pain severity and pain interference with interference with daily activities entailing 7 of the questions.
Patient's will rate their pain interference over the past week, on a 0-10 scale with a higher score reflecting more interference with activities.
End points include 0 which equals "does not interfere" and 10 which equals "completely interferes."
Answers to each of the 7 questions will be reported as mean values for each time point (Month 1, 3, and 6).
|
Up to 6 months
|
Mean Symptom Distress Score
Time Frame: 1 week & 1 month
|
The Opioid-Related Symptom Distress Scale (OR-SDS) will be used to assess subject-reported levels of frequency and severity of 10 symptoms known to be associated with opioid medication usage, such as drowsiness, dizziness, and constipation.
Added to this measure are 5 other symptoms (including shortness of breath, falls, abdominal pain, bloody stool, and 'other'), reflecting side effects for patients taking NSAIDs or acetaminophen.
Symptom frequency will be rated as: 1=rarely, 2=occasionally, 3=frequently, or 4=almost constantly, with higher ratings indicating more frequent symptoms (ranging from 1 to 4).
Symptom severity will be rated as: 1=slightly, 2-moderate, 3=severe, or 4=very severe, with higher ratings indicating more severe symptoms (ranging from 1 to 4).
Patients who deny a symptom will be given a score of zero for frequency and severity.
A mean symptom distress score was calculated for each arm based on patient reported scores for severity and frequency.
|
1 week & 1 month
|
Percent of Participants With Opioid Use During the Past Week
Time Frame: 1, 3, 6, and 12 months
|
Patients will be asked if they have used opioids during the past week at each of the follow-up time points.
This will be a dichotomous outcome in which 'yes' will indicate opioid use in the past week and 'no' will indicate no opioid use in the past week.
|
1, 3, 6, and 12 months
|
PROMIS Measure: Mean T-score Physical Function-4
Time Frame: 1, 3, 6, and 12 months
|
Patient report of physical function will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function-4 for chores, ability to use stairs, walking, and running errands on a 5-point scale with end points of "without any difficulty" and "unable to do."
Higher scores reflect less difficulty.
T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points.
Therefore a person with a T-score of 40 is one SD below the mean.
These values will be compared to the value obtained from the baseline assessment with patients reporting their function prior to injury.
The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome).
|
1, 3, 6, and 12 months
|
PROMIS Measure: Mean T-score Global Health-Physical 2a
Time Frame: 1, 3, 6, and 12 months
|
Patient reported global health will be measured using the PROMIS Global Health-Physical 2a.
General physical health is measured on a 5-point scale with end points of "excellent" and "poor," where higher scores reflect better physical health.
Ability to carry out every day physical activities is measured on a 5 point scale with end points of "completely" and "not at all," where higher scores reflect better ability.
T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points.
Therefore a person with a T-score of 40 is one SD below the mean.
These values will be compared to the value obtained from the baseline assessment with patients reporting their global health prior to injury.
The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome).
|
1, 3, 6, and 12 months
|
Healthcare Utilization, Mean Days in the Hospital
Time Frame: Up to 12 months
|
The number of days the patient spent in the hospital after ED discharge will be collected through patient report and the patient's electronic health record.
Analysis will compare these outcomes among study arms.
|
Up to 12 months
|
Healthcare Utilization, Mean Number of Visits to ED/Urgent Care
Time Frame: Up to 12 months
|
The number of visits to an ED or urgent care will be collected through patient report and the patient's electronic health record.
Analysis will compare these outcomes among study arms.
|
Up to 12 months
|
Healthcare Utilization, Mean Number of Visits to Primary Care Provider
Time Frame: Up to 12 months
|
The number of visits to a primary care provider's office will be collected through patient report and the patient's electronic health record.
Analysis will compare these outcomes among study arms.
|
Up to 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Michelle Meyer, PhD, MPH, University of North Carolina, Chapel Hill
Publications and helpful links
General Publications
- Platts-Mills TF, Hollowell AG, Burke GF, Zimmerman S, Dayaa JA, Quigley BR, Bush M, Weinberger M, Weaver MA. Randomized controlled pilot study of an educational video plus telecare for the early outpatient management of musculoskeletal pain among older emergency department patients. Trials. 2018 Jan 5;19(1):10. doi: 10.1186/s13063-017-2403-8.
- Gan TJ, Joshi GP, Zhao SZ, Hanna DB, Cheung RY, Chen C. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiol Scand. 2004 Oct;48(9):1194-207. doi: 10.1111/j.1399-6576.2004.00495.x.
- Hurka-Richardson K, Platts-Mills TF, McLean SA, Weinberger M, Stearns SC, Bush M, Quackenbush E, Chari S, Aylward A, Kroenke K, Kerns RD, Weaver MA, Keefe FJ, Berkoff D, Meyer ML. Brief Educational Video plus Telecare to Enhance Recovery for Older Emergency Department Patients with Acute Musculoskeletal Pain: an update to the study protocol for a randomized controlled trial. Trials. 2022 May 12;23(1):400. doi: 10.1186/s13063-022-06310-z.
- Platts-Mills TF, McLean SA, Weinberger M, Stearns SC, Bush M, Teresi BB, Hurka-Richardson K, Kroenke K, Kerns RD, Weaver MA, Keefe FJ. Brief educational video plus telecare to enhance recovery for older emergency department patients with acute musculoskeletal pain: study protocol for the BETTER randomized controlled trial. Trials. 2020 Jul 6;21(1):615. doi: 10.1186/s13063-020-04552-3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-0204
- R01AG058702 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic
-
Apurano Pharmaceuticals GmbHRecruitingPain | Lower Back Pain | Back Pain | Chronic Pain | Pain, Chronic | Chronic Pain Syndrome | Pain Syndrome | Lower Back Pain ChronicGermany
Clinical Trials on Educational Video
-
Drexel UniversityCompletedOther Surgical Procedures
-
St. Joseph's Healthcare HamiltonNot yet recruitingBody Image | Eating, Healthy
-
Black Hills State UniversityNational Institute of General Medical Sciences (NIGMS)Recruiting
-
Elizabeth MuellerCompletedPelvic Floor Disorders | Patient ComplianceUnited States
-
University of California, IrvineKaiser PermanenteUnknownStress Urinary Incontinence | Knowledge, Attitudes, PracticeUnited States
-
University of Illinois at ChicagoActive, not recruiting
-
George Washington UniversityCompletedHuman Papilloma Virus | Cervical DysplasiaUnited States
-
Sun Yat-sen UniversityWenzhou Medical UniversitySuspended
-
University of PittsburghCompleted